FDA issues final guidance on heparin testing
June 27, 2013Manufacturing and Production, Sales and Marketing FDA, heparin
Five years after the adulterated heparin scandal that claimed the lives of dozens of people in the US alone, the …
ImmTAC deal for Immunocore
June 27, 2013Research and Development, Sales and Marketing Genentech, ImmTAC, oxford biotech
Oxford-based biotech company Immunocore has signed what could be a $300 million deal with Genentech to discover and bring to …
Oxford BioTherapeutics hires chairman
June 27, 2013Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics, morton
Biotech firm Oxford BioTherapeutics has appointed Bryan Morton to be the company’s new non-executive chairman. Morton has over 30 years’ …
Contract research news in brief
June 27, 2013Research and Development PRA International, Parexel, Quanticate, TKL, WIL Research
A round-up of recent developments in the contract research sector, including KKR’s acquisition of PRA, a new Parexel business unit …
Astellas in $500m deal with Cytokinetics
June 27, 2013Sales and Marketing Astellas, cytokinetics
Astellas Pharma could pay out $40 million over the next two years to US firm Cytokinetics as part of a …
Heart failure treatment given Breakthrough Status
June 27, 2013Sales and Marketing Breakthrough Therapy Designation, Novartis, RLX03O, serelaxin
Novartis’ new treatment for heart failure has been granted Breakthrough Therapy designation status by the FDA. RLX030 (serelaxin) is for …
Xtandi gets EU approval
June 26, 2013Sales and Marketing Astellas, FDA, Xtandi
Astellas Pharma’s Xtandi has been approved in the European Union for the treatment of adult men with advanced prostate cancer, …
NICE finalises tamoxifen guidance
June 26, 2013Sales and Marketing Evista, NICE, lilly, tamoxifen
Women at risk of breast cancer can now be offered a daily pill on the NHS to stop the disease …
Allergan announces new president
June 26, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, ingram
Allergan has hired Douglas Ingram to be its president and lead the company’s global commercial operations. In this newly established …
Sanofi chief executive to lead EFPIA
June 26, 2013Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty
Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …
Ranbaxy facing another facility problem?
June 26, 2013Manufacturing and Production FDA, Ranbaxy
Another facility operated by Ranbaxy Laboratories in India is reported to have failed an inspection by the FDA, potentially adding …
NICE completes Forxiga U-turn
June 26, 2013Sales and Marketing BMS, Forxiga, NICE
Bristol-Myers Squibb and AstraZeneca are celebrating after NICE reversed its decision from earlier this year and is now recommending their …
Merck Serono censured over calls
June 25, 2013Medical Communications, Sales and Marketing ABPI, Erbitux, Merck Serono, PMCPA
A Merck Serono medical representative has been accused of ‘harassing’ an anonymous health professional by requesting a meeting every month …
Lilly diabetes drug beats rivals
June 25, 2013Sales and Marketing BMS, diabetes, dulaglutide, lilly
New clinical trial results have shown Lilly’s investigational type 2 diabetes drug has beaten its three nearest rivals in reducing …
Roger Graham appointed president of Mylan Specialty
June 25, 2013Manufacturing and Production, Research and Development, Sales and Marketing Mylan, graham, specialty
Mylan has hired previous J&J vice president Roger Graham to be president of its specialty business. Graham will report to …
US gains exemption from EU requirements on API imports
June 25, 2013Manufacturing and Production API, FDA, hamburg
The US has joined the short list of countries from which suppliers can ship active pharmaceutical ingredients into the EU …
GSK mulling sales of thrombosis brands and facility to Aspen
June 24, 2013Manufacturing and Production, Sales and Marketing Arixtra, GSK, aspen
GlaxoSmithKline says it is considering an offer from South African drugmaker Aspen Pharmacare to take ownership of two thrombosis drugs …
BMS appoints Harman International chief executive
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing BMS
Bristol-Myers Squibb has appointed Harman’s chief executive Dinesh Paliwal to its Board of directors.Paliwal will serve as a member of …
Viagra patent expiry opens up market
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing ED, Pfizer, generics, viagra
Pfizer lost its UK patent rights to its erectile dysfunction drug Viagra over the weekend, leading to an influx of …
Lundbeck cuts more jobs in Europe
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing Lexapro, Lundbeck, cuts
Lundbeck is to cut yet more jobs in Europe as the Danish pharma firm restructures its operations to focus on …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
